Skip Navigation LinksHome > February 2010 - Volume 26 - Issue 2 > Use of Low-dose Ketamine Infusion for Pediatric Patients Wit...
Clinical Journal of Pain:
doi: 10.1097/AJP.0b013e3181b511ab
Case Reports

Use of Low-dose Ketamine Infusion for Pediatric Patients With Sickle Cell Disease-related Pain: A Case Series

Zempsky, William T. MD* †; Loiselle, Kristin A. BS*; Corsi, John M. BS, MBA*; Hagstrom, J. Nathan MD* †

Collapse Box


Objectives: Sickle cell disease-related pain is difficult to treat adequately. Pain secondary to vasoocclusive episodes (VOE) may be unresponsive to high-dose intravenous opiates. Alternative treatment options for VOE are needed. We sought to review our experience with low-dose ketamine for children hospitalized with VOE.

Methods: Retrospective medical chart reviews were conducted for hospitalized patients treated with ketamine for sickle cell VOE. Data gathered included vital signs, pain scores, opiate utilization, and adverse events.

Results: Five children and adolescents received a low-dose ketamine infusion for the treatment of sickle cell-related pain. Four received the infusion in addition to opiates (delivered via patient controlled analgesia) as a rescue intervention after several days of inadequate pain relief and 1 patient received ketamine in place of opiates. Two of the 5 patients achieved what seems to be clinically significant pain control with a low-dose ketamine infusion, whereas 1 additional patient had significant reduction in opiate utilization.

Discussion: Further research into ketamine for vasoocclusive pain is warranted.

© 2010 Lippincott Williams & Wilkins, Inc.

Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.